OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts
Z. Y. Chen, Wei Wei, Z-X Guo, et al.
British Journal of Cancer (2013) Vol. 110, Iss. 3, pp. 733-740
Open Access | Times Cited: 22

Showing 22 citing articles:

Therapeutic options in hepatocellular carcinoma: a comprehensive review
Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 6, pp. 1901-1916
Open Access | Times Cited: 41

Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
Sin-Ting Wang, Shi‐Wei Huang, Kuang-Ting Liu, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 33

CXCL13 rather than IL-31 is a potential indicator in patients with hepatocellular carcinoma
Bing Li, Huiting Su, Ju Cao, et al.
Cytokine (2016) Vol. 89, pp. 91-97
Closed Access | Times Cited: 38

Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma
Vikrant Rai, Joe Abdo, Abdullah Alsuwaidan, et al.
Molecular and Cellular Biochemistry (2017) Vol. 437, Iss. 1-2, pp. 13-36
Closed Access | Times Cited: 36

Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy
Hanmin Li, Lisheng Zhang
Oncotarget (2016) Vol. 8, Iss. 1, pp. 1805-1813
Open Access | Times Cited: 27

Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma
Mengjie Yang, Jie Guo, Yan‐Fang Ye, et al.
Cancer Communications (2018) Vol. 38, Iss. 1, pp. 1-14
Open Access | Times Cited: 17

Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis
Zulei Zhang, Yuting Chen, Yaofei Jiang, et al.
Cancer Biology & Therapy (2019) Vol. 20, Iss. 11, pp. 1380-1388
Open Access | Times Cited: 17

Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma
Bo‐Gen Ye, Hui‐Chuan Sun, Xiao‐Dong Zhu, et al.
Oncotarget (2016) Vol. 7, Iss. 20, pp. 29333-29345
Open Access | Times Cited: 16

Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection
Jiong Wu, Xiaolu Ma, Lu Tian, et al.
Journal of Cancer (2017) Vol. 8, Iss. 8, pp. 1338-1346
Open Access | Times Cited: 16

Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
Inga Hochnadel, Uta Kossatz-Boehlert, Nils Jedicke, et al.
Human Vaccines & Immunotherapeutics (2017) Vol. 13, Iss. 12, pp. 2931-2952
Open Access | Times Cited: 15

Association between inflammatory cytokines and long-term adverse outcomes in acute coronary syndromes: A systematic review
Gisela A. Kristono, A. Holley, Prashant Lakshman, et al.
Heliyon (2020) Vol. 6, Iss. 4, pp. e03704-e03704
Open Access | Times Cited: 14

Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma
Bibek Aryal, Munekazu Yamakuchi, Toshiaki Shimizu, et al.
Canadian Journal of Gastroenterology and Hepatology (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 13

<p>Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma</p>
Leung Li, Stephen L. Chan, Frankie Mo, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 2719-2727
Open Access | Times Cited: 9

Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma
Lianghe Lu, Weiwei, Anna Kan, et al.
Disease Markers (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 5

Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization
Jella‐Andrea Abraham, Kristina Yeghiazaryan, Olga Golubnitschaja
Personalized Medicine (2016) Vol. 13, Iss. 4, pp. 347-360
Closed Access | Times Cited: 3

Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production.
Taro Sakamoto, Yuji Ishii, Hiroaki Shiba, et al.
PubMed (2016) Vol. 36, Iss. 7, pp. 3301-6
Closed Access | Times Cited: 2

Indications of pro-inflammatory cytokines in laparoscopic and open liver resection for early-stage hepatocellular carcinoma
TP Ng, Li Pang, Jiaqi Wang, et al.
Hepatobiliary & pancreatic diseases international (2023) Vol. 23, Iss. 3, pp. 257-264
Closed Access | Times Cited: 1

Expression of 10 circulating cytokines/chemokines in HBV-related liver disease
Yanfang Jia, Xiaolei Jiao, Wenxia Shi, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access

Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma
Bilger Çavuş, Filiz Akyüz, Raım Iliaz, et al.
Experimental Oncology (2020) Vol. 42, Iss. 3, pp. 208-214
Open Access | Times Cited: 2

Hepatopulmonary syndrome delays postoperative recovery and increases pulmonary complications after hepatectomy
Yujie Li, Xuehong Bai, Xi Tang, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 33, Iss. 1S, pp. e449-e457
Closed Access | Times Cited: 2

Inflammatory profiles in acute coronary syndromes
Gisela A. Kristono
(2021)
Closed Access

Page 1

Scroll to top